Skip to main content

Table 1 State variables of the agents

From: Economic impact of generic antiretrovirals in France for HIV patients’ care: a simulation between 2019 and 2023

Age

Years

Duration of the current treatment

Years

Duration of the HIV infection

Years

Country of birth

France

Other

Gender

Male

Female

Transmission mode

MSM

Other

Cardiovascular disease

Yes

No

Diabetes

Yes

No

AIDS diagnosis

Yes

No

Creatinine clearance (mL / min / 1.73 m2)

Low (≤ 29)

Medium (>  29 and ≤ 89)

High (>  89)

HIV RNA (viral load, in copies / mL)

Low (≤ 50)

Medium (>  50 and ≤ 10,000)

High (>  10,000)

  1. MSM indicates Man who has Sex with Man, AIDS Acquired Immunodeficiency Syndrome, HIV Human Immunodeficiency Virus, RNA RiboNucleic Acid